<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Piumatti, Giovanni</dc:creator>
  <dc:creator>Amati, Rebecca</dc:creator>
  <dc:creator>Richard, Aude</dc:creator>
  <dc:creator>Baysson, Hélène</dc:creator>
  <dc:creator>Purgato. Marianna</dc:creator>
  <dc:creator>Guessous, Idris</dc:creator>
  <dc:creator>Stringhini, Silvia</dc:creator>
  <dc:creator>Albanese, Emiliano</dc:creator>
  <dc:date>2022</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">(1) Mental health may modulate the perceived risk of SARS-CoV-2 infection. However, it is unclear how psychological symptoms may distort symptom perception of COVID-19 and SARS-CoV-2 infection. We assessed whether depressive symptoms predicted self-reported COVID-19 symptoms, independently of serologically confirmed SARS-CoV-2 infection. (2) Participants (aged 20–64) in the Geneva (N = 576) and Ticino (N = 581) Swiss regions completed the Patient Health Questionnaire before being tested for anti-SARS-CoV-2 IgG antibodies and recalled COVID-19-compatible symptoms on two occasions: April–July 2020 (baseline), and January–February 2021 (follow-up). We estimated prevalence ratios for COVID-19 symptoms by depression scores in interaction with serological status. (3) At baseline, in Geneva, higher depression predicted higher probability of reporting systemic, upper airways, and gastro-intestinal symptoms, and fever and/or cough; in Ticino, higher depression predicted systemic, upper airways, and gastro-intestinal symptoms, fever and/or cough, dyspnea, and headache. At follow-up, in Geneva, higher depression predicted higher probability of reporting systemic symptoms and dyspnea; in Ticino, higher depression predicted higher probability of reporting systemic and upper airways symptoms, dyspnea and headache (all p values &lt; 0.05). (4) We found positive associations between depressive symptoms and COVID-19-compatible symptoms, independently of seropositivity. Mental wellbeing has relevant public health implications because it modulates self-reported infection symptoms that inform testing, self-medication, and containment measures, including quarantine and isolation.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/331765</dc:identifier>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1331765</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/331765/files/Albanese_2022_MDPI_ijerph_Associations between depression.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3390/ijerph192416696</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1331765</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>International Journal of Environmental Research and Public Health. - 2022, vol. 19, p. 16696</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">COVID-19</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Depressive symptoms</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Seropositivity</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Population-based observational study</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns5="xml" ns5:lang="en">Associations between depression and self-reported COVID-19 symptoms among adults : results from two population-based seroprevalence studies in Switzerland</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
